Illness	Number of cases
Lymphoid leukaemia - Acute lymphoblastic leukemia not having achieved remission (C91.00)	390
Purpura and other haemorrhagic conditions (D69.58)	49
Malignant neoplasm of brain - Malignant neoplasm of cerebellum (C71.6)	42
Drug-induced aplastic anemia (D61.10)	37
Thalassaemia - Beta thalassemia (D56.1)	29
Hodgkin lymphoma (C81.1)	28
Malignant neoplasm of adrenal gland (C74.1)	27
Malignant neoplasm of other connective and soft tissue - Malignant neoplasm of connective and soft tissue of pelvis (C49.5)	24
Malignant neoplasm of kidney except renal pelvis (C64)	23
Malignant neoplasm of other connective and soft tissue - Malignant neoplasm of connective and soft tissue of thorax (C49.3)	19

Top 10 treatments

Treatment	Number
Administration of medicines to sedate and eliminate pain (8-903)	278
(9-985.0)	277
(1-999.3)	232
(9-984.8)	224
Examination of the cerebrospinal fluid spaces (1-204.2)	219
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	209
(9-984.7)	199
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.0)	171
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	149
Computer-assisted analysis of the images with 3D-analysis (3-990)	147

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 1005

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Chronische obstruktive Lungenerkrankung (COPD)

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ08
CQ01
CQ02
CQ05

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
447	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
37	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
16	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Doctoral supervision	Medizinische Fakultät
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year)
Editors of scientific journals/textbooks
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies
Lectureships / teaching posts at universities of applied sciences
Lectureships / teaching posts at colleges and universities

Training

No.	Training in other healing professions	Comment
HB17	Auxiliary nurse (m/f)
HB13	Medical technical assistant for functional diagnostics (MTAF) (m/f)
HB12	Medical technical laboratory assistant (MTLA) (m/f)
HB14	Orthoptist (m/f)
HB07	Surgical technical assistant (m/f)
HB02	Health and paediatric nurse (m/f)
HB10	Midwife (m/f)
HB05	Medical technical radiology assistant (MTRA) (m/f)
HB01	Nurse and health care worker (m/f)
HB03	Physical therapist / physiotherapist (m/f)
HB16	Dietician (m/f)